Lilly expands its line of bowel illness drugs with a $3.2 billion acquisition of Morphic
The Acquisition Details Eli Lilly has offered $57 per share for Morphic Holding, representing a substantial 79% premium over Morphic's ...
wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/investorbytes.com/httpdocs/wp-includes/functions.php on line 6114The Acquisition Details Eli Lilly has offered $57 per share for Morphic Holding, representing a substantial 79% premium over Morphic's ...
With its goal of curbing uncontrollably high health care costs, California's Office of Health Care Affordability is up against an ...
According to a new study, older women with chronic renal disease may end up losing so many teeth that it ...
Health experts have warned that Australian newborns are becoming sicker than ever after receiving a potentially hazardous colic medication. According ...
On Tuesday, the Senate passed a bill that specifically authorizes states to use federal funds totaling millions of dollars to ...
YORK – WellSpan Health and Jersey College, an accredited post-secondary institution specializing in nursing education, have received regulatory approval to ...
Ever wondered why some kids in your child's class seem to be more restless or struggle more with attention? A ...
Boxing legend Mike Tyson recently assured fans that he is feeling "100%" after experiencing a medical issue during a flight ...